Hattie Hayes is the editor of Ophthalmology Times Europe.
Genetic and Gender Factors Linked to Fuchs Endothelial Corneal Dystrophy in University College London Study
These findings could support gene therapies targeting CTG18.1 that are currently in development.
SpliceBio Doses First Patient in Trial for Stargardt Gene Therapy SB-007
The ASTRA and accompanying POLARIS studies are actively enrolling patients.
Ocugen’s Geographic Atrophy and Stargardt Gene Therapies Garner Positive ATMP Opinions from EMA
According to Ocugen, the EMA has granted OCU410 and OCU410ST Advanced Therapy Medicinal Product classification.